| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.00072 | 1 |